ClinicalTrials.gov
ClinicalTrials.gov Menu

Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy (ADI-PEG 20)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01287585
Recruitment Status : Completed
First Posted : February 1, 2011
Last Update Posted : August 26, 2016
Sponsor:
Information provided by (Responsible Party):
Polaris Group